Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Disanto

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 28, 2012
Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin?Giulio Disanto, Sreeram V Ramagopalan
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 11, 2013
On the sex ratio of multiple sclerosisGiulio Disanto, Sreeram V Ramagopalan
Neurology|November 8, 2013
Similar genetics of adult and pediatric MS: age is just a numberGiulio Disanto, Sreeram V Ramagopalan
Annals of Neurology|October 30, 2010
Visceral obesity and brain volumeAdam E Handel, Giulio Disanto, Sreeram V Ramagopalan
Methods in Molecular Biology (Clifton, N.J.)|February 18, 2015
Neurofilament Light Chain Determination from Peripheral Blood SamplesMarguerite Limberg, Giulio Disanto, Christian Barro, et al.
BMC Neurology|September 6, 2017
Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE studyChiara Zecca, Giulio Disanto, Sarah Mühl, et al.
Patient Preference and Adherence|August 30, 2014
Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatmentMatteo Caporro, Giulio Disanto, Claudio Gobbi, et al.
Fertility and Sterility|November 9, 2010
Estrogen-vitamin D interaction in multiple sclerosisGiulio Disanto, Adam E Handel, Sreeram V Ramagopalan
Expert Review of Neurotherapeutics|February 2, 2013
Next-generation sequencing in understanding complex neurological diseaseAdam E Handel, Giulio Disanto, Sreeram V Ramagopalan
CNS & Neurological Disorders Drug Targets|May 16, 2012
Multiple sclerosis: risk factors and their interactionsGiulio Disanto, Julia M Morahan, Sreeram V Ramagopalan
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 28, 2012
Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin?Giulio Disanto, Sreeram V Ramagopalan
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 11, 2013
On the sex ratio of multiple sclerosisGiulio Disanto, Sreeram V Ramagopalan
Neurology|November 8, 2013
Similar genetics of adult and pediatric MS: age is just a numberGiulio Disanto, Sreeram V Ramagopalan
Annals of Neurology|October 30, 2010
Visceral obesity and brain volumeAdam E Handel, Giulio Disanto, Sreeram V Ramagopalan
Methods in Molecular Biology (Clifton, N.J.)|February 18, 2015
Neurofilament Light Chain Determination from Peripheral Blood SamplesMarguerite Limberg, Giulio Disanto, Christian Barro, et al.
BMC Neurology|September 6, 2017
Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE studyChiara Zecca, Giulio Disanto, Sarah Mühl, et al.
Patient Preference and Adherence|August 30, 2014
Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatmentMatteo Caporro, Giulio Disanto, Claudio Gobbi, et al.
Fertility and Sterility|November 9, 2010
Estrogen-vitamin D interaction in multiple sclerosisGiulio Disanto, Adam E Handel, Sreeram V Ramagopalan
Expert Review of Neurotherapeutics|February 2, 2013
Next-generation sequencing in understanding complex neurological diseaseAdam E Handel, Giulio Disanto, Sreeram V Ramagopalan
CNS & Neurological Disorders Drug Targets|May 16, 2012
Multiple sclerosis: risk factors and their interactionsGiulio Disanto, Julia M Morahan, Sreeram V Ramagopalan
Pageof 13